N/A
N=186
Evaluation of Micropore"s SpiraLith Absorbents
Airway Management During Operative Procedure
Bottom Line
View on ClinicalTrials.gov: NCT02550470 ↗Enrolled (actual)
186
Serious AEs
0.0%
Results posted
Apr 2022
Primary outcome: Primary: Duration of Use Under Clinical Anesthesia of Each Absorbent — 1931; 1806; 1527 min
Study Design & Population
- Study type
- Observational
- Phase
- N/A
- Interventions
- Carbon Dioxide Absorbents (Device); Micropore SpiraLith (Device); Sevoflurane (Drug)
- Age
- Pediatric, Adult, Older Adult
- Sex
- All
- Sponsor
- Rutgers, The State University of New Jersey
- Primary completion
- Oct 2016
Outcome Measures
| Outcome | Result | p-value |
|---|---|---|
| PRIMARY Duration of Use Under Clinical Anesthesia of Each Absorbent |
1931; 1806; 1527 | — |
| SECONDARY Cost of Each Absorbent's Use |
— | — |
Summary
This is an observational study investigating the duration of use and cost of the new CO2 absorbent Micropore's Spiralith®, compared to Drägersorb® 800+, Drägersorb® Free.
Eligibility Criteria
Inclusion Criteria
- All comers to the 3 designated Operating Rooms.
Exclusion Criteria
- None
Data sourced from ClinicalTrials.gov (NCT02550470). Outcome figures and adverse-event rates are extracted automatically from the registry's posted results and are provided for clinician reference, not as a substitute for the primary publication.